5AM Ventures is a venture capital firm investing in primarily in life science companies and was founded in 2002 by Andrew Schwab and John Diekman. The companies in the firm's portfolio are in the industries of healthcare, biopharmacuticals, life sciences, medical technology, and research instruments. The companies in the portfolio have more than 35 clinical trials in process (as of 2019) in order to create breakthroughs using the technology built by its start-up companies.
The firm has raised eight funds since 2002, totaling more than one billion dollars. Investors have included institutional investors, funds-of-funds, family offices, foundations, and endowments.
5AM Ventures was founded.
A biotechnology and software company offering prescription digital therapeutics.
A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease
A company developing therapies for psychological and neurological illnesses
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease.
Vor BioPharma is a biotechnology company developing hematopoietic stem cell therapy treatments for cancer.
A company focused on developing chemical process technology for production of chemicals from renewable feedstocks
A medical device company developing tools for orthopedic surgeons
A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
A pharmaceutical company engaged in the discovery, development and commercializtion of antibacterials for the treatment of infections
American biotechnology company
A company developing inhaled therapies to treat, prevent the spread of infectious and progressive respiratory diseases
A antiviral therapeutics company developing drugs for chronic Hepatitis B
A protein analysis company developing products and systems to analyze protein
A biomedical company that develops medical devices
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
A biopharmaceutical company that develops antibody-based therapeutics to treat cancer
A drug discovery and developement company focused on therapeutics for diabetes and obesity
A company developing macromolecular therapeutics to treat diseases
Impel NeuroPharma is a Seattle-based healthcare company.
Now Millendo, is working on treatments for severe endocrine diseases
scPharmaceuticals is a Burlington, Massachusetts-based company.
Associated investment funds
Andrew J. Schwab
Managing Partner and Co-Founder
Managing Partner and Co-Founder
Kush M Parmar, MD, PhD
5AM Ventures raises nearly half a billion for 2 new VC funds
February 13, 2019
Documentaries, videos and podcasts
- Venture capitalA form of financing or funding for emerging companies. Investment on early-stage companies in exchange for equity in the companies they invest in.
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- Synthetic biologyInterdisciplinary branch of biology and engineering, applying multiple disciplines to build artificial biological systems for research, engineering, and medical applications.